## Abstract Synthetic human pancreatic growth hormone‐releasing factor (hpGRF) was injected intraperitoneally in different dosages, either as one injection or two injections 3 hours apart, into goldfish. Serum GH levels were increased by certain dosages of hpGRF under both treatments. This is the f
Growth-hormone releasing hormone in a bronchial carcinoid
✍ Scribed by Rudolf M. Huber; Jochen Schopohl; Marco Losa; Gernot Wolfram; Olaf Thetter; Willibald Permanetter; Klaus V. Werder
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 582 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The case is reported of a 43-year-old patient with a peripherally located bronchial carcinoid tumor containing large amounts of immunoreactive and bioactive growth-hormone releasing hormone (GHRH). Because no GHRH was found in the peripheral circulation, there was no quantitative or qualitative derangement of growth-hormone secretion. The tumor was excised completely by thoracotomy. Cancer 679538-2542,1991.
RONCHIAL CARCINOIDS can secrete t u m o r markers B like hormones which may or may not lead to clinical symptoms. One of the tumor markers secreted by pulmonary nodules is growth-hormone releasing h o r m o n e ( G H R H ) which may cause acromegaly,'.' although ectopic production of GHRH as a cause of acromegaly is less than l%.3 We report on a 43-year-old w o m a n in whom a bronchial carcinoid of the peripheral type was diagnosed by bronchoscopy. Although this patient had no clinical symptoms which might have been attributed to elevated GH levels, the tumor was found to harbor large amounts of biologically active GHRH.
Case Report
The 43-year-old woman was admitted to the hospital because she complained of persistent coughing after a cold 4 weeks before. She was in good physical and mental condition. Ten years ago she stopped occasional smoking. She worked as a salesperson.
There was no known exposure to toxic or carcinogenic substances and no family history of cancer. Her weight was 68 kg and height 160 cm. With the exception of a small diffuse goiter, there was no pathologic clinical finding; in particular no clinical chest ab- normality and no clinical signs of acromegaly were found.
Chest radiography revealed a nodule with the density of soft tissue near the right margin of the heart that appeared to have smooth borders by tomography. It was 13 to 16 cm deep within From the 'Medizinische Klinik Innenstadt,
📜 SIMILAR VOLUMES
In situ hybridization allows the detection and measurement of specific messenger RNAs in individual hypothalamic neurons, and has shown, among magnocellular neurons, not only which cells express the genes for oxytocin and vasopressin but also how they change with physiological stimulation. With this
Using a molecular analysis of the DNA from a patient with a deletion of chromosome 20 [46,XX,de1(20)(pl1.23)1, we have excluded the growth hormone-releasing hormone (GHRH) gene from the region 20p11.23+pter. The patient had minor facial anomalies, Rieger eye anomaly, a congenital heart defect, sever
## Abstract Utilizing an immunoperoxidase technique at the light microscope level, growth hormone‐release‐inhibiting hormone (somatostatin) was localized in the external zone of the median eminence, the subcommissural organ, the organum vasculosum of the lamina terminal is and the pineal gland. No
## Abstract Internalization and intracellular trafficking of the growth hormone‐releasing hormone receptor (GHRH‐R) were studied in rat anterior pituitary and human (h) and rat (r) GHRH‐R‐transfected BHK cells, with the GHRH agonist, [N^α^‐5‐carboxyfluoresceinyl‐D‐Ala^2^, Ala^8^, Ala^15^, Lys^22^]h